One anastomosis gastric bypass surgery in Type2 diabetes patients with body mass index35 kg/m

Autor: Alireza, Amirbeigi, Fereshteh, Abbaslou, Mohammad, Talebpour, Ahmadreza, Soroush, Fezzeh, Elyasinia, Hossein, Zabihi Mahmoudabadi, Khosrow, Najjari
Rok vydání: 2022
Zdroj: Annals of medicine and surgery (2012). 79
ISSN: 2049-0801
Popis: Bariatric surgeries have shown efficacy in weight reduction, glycemic control and improvement of type-2 diabetes (T2DM) in patients with obesity. We aimed to assess the efficacy of one anastomosis gastric bypass surgery (OAGB) in T2DM patients with body mass index (BMI) 35 kg/mIn this multicenter retrospective cohort study, 14 T2DM patients with BMI35 kg/mNo adverse outcomes were detected 12 months after surgery. Within six months, seven (50%) patients underwent remission (one (7.1%) within one, three (21.4%) within three, and three (21.4%) within six months). Post-operative weight (p 0.001) and fasting blood glucose (p 0.01) in all time periods were significantly lower compared to pre-operative values. Hemoglobin A1C (HbA1C) was significantly lower at three- and six-month intervals (p 0.05) but not at twelve months (p = 0.2). Thyroid-stimulating hormone and triglyceride levels were lower at six months compared to pre-surgical levels (p 0.05) but cholesterol levels were not different in any of time points (p 0.05).OAGB surgery is associated with weight reduction, glycemic control and a 50% remission rate within six months in patients with diabetes and BMI35 kg/m
Databáze: OpenAIRE